Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa

Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study

(2018) McNeil Ngongondo et al.   BMC INFECTIOUS DISEASES

Estimated use of abacavir among adults and children enrolled in public sector antiretroviral therapy programmes in Gauteng, South Africa

(2017) D Evans et al.   SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE

Changes in second-line regimen durability and continuity of care in relation to national ART guideline changes in South Africa

(2016) Dorina Onoya et al.   Journal of the International AIDS Society

The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study

(2016) Janne Estill et al.   Lancet HIV

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa

(2015) Laura Ciaffi et al.   AIDS

Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial

(2015) Alejandro Arenas-Pinto et al.   JOURNAL OF NEUROVIROLOGY

Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants

(2014) Ronald Kiguba et al.   BMJ Open

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

(2012) Mattia CF Prosperi et al.   BMC INFECTIOUS DISEASES

Cohort Profile: The Themba Lethu Clinical Cohort, Johannesburg, South Africa

(2012) Matthew P Fox et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa

(2012) Matthew P. Fox et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Sex Differences in the Incidence of Peripheral Neuropathy Among Kenyans Initiating Antiretroviral Therapy

(2011) S. A. Mehta et al.   CLINICAL INFECTIOUS DISEASES

Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa

(2010) Andrew Boulle et al.   AIDS

Changes in Programmatic Outcomes During 7 Years of Scale-up at a Community-Based Antiretroviral Treatment Service in South Africa

(2010) Mweete D Nglazi et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

(2009) Anouk M Kesselring et al.   AIDS

Initiation of Antiretroviral Therapy at CD4 Cell Counts ≥350 Cells/mm3 Does Not Increase Incidence or Risk of Peripheral Neuropathy, Anemia, or Renal Insufficiency

(2009) Kenneth A Lichtenstein et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Gender Differences in Discontinuation of Antiretroviral Treatment Regimens

(2009) Mirjam-Colette Kempf et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study

(2009) Ian M Sanne et al.   Journal of the International AIDS Society